FEMASYS INC. - COMMON STOCK

Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update

27 مارس 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations

19 مارس 2025 08:20:00 بحسب Nasdaq GlobeNewswire

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

18 مارس 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

13 مارس 2025 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials

25 فبراير 2025 08:20:00 بحسب Nasdaq GlobeNewswire

Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

11 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

04 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control

30 يناير 2025 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment

16 يناير 2025 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed

03 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

26 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update

12 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys to Exhibit at the Annual AAGL 2024 Global Conference

07 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

01 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed

30 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

10 أكتوبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

08 أكتوبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

02 أكتوبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys Announces Infertility Clinic Customers from Coast to Coast

18 سبتمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market

11 سبتمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire